First-in-Class Pipeline Targeting RNA Modifying Enzymes

STORM’S Novel, Proprietary Pipeline

At the core of our R&D strategy is the development and use of cutting-edge techniques such as chemical biology, RNA-Sequencing, RNA mass spectrometry and functional genomics to elucidate the functional role of diverse RNA modifications. Using these latest insights, we have built a unique target discovery platform for the identification of new drug targets and we continue to develop state-of-the-art computational biology analysis methods to support the identification and validation of novel and clinically relevant targets.

The experience and capabilities STORM has developed can be readily applied to many disease indications and enable exploration of the untapped RNA modification enzyme target opportunity.